| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
GSK 0660
|
1014691-61-2 |
GSK0660
|
3-[[[2-甲氧基-4-(苯基氨基)苯基]氨基]磺酰基]-2-噻吩羧酸甲酯
|
C19H18N2O5S2 |
418 | |
|
T0901317
|
293754-55-9 |
N-(2,2,2-三氟乙基)-N-[4-[2,2,2-三氟-1-羟基-1-(三氟甲基)乙基]苯基]苯磺酰胺
|
N-(2,2,2-三氟乙基)-N-[4-[2,2-三氟-1-羟基-1-(三氟甲基)乙基]苯基]苯磺酰胺;T0901317;T 0901317;T-0901317;CS-721
|
C17H12NO3F9S |
481.33268 | |
|
MPEP
|
96206-92-7 |
MPEP
|
2-甲基-6-(苯乙炔)吡啶盐酸盐;2-甲基-6-(苯基乙炔基)吡啶;CS-715;MPEP 100MG
|
C14H11N.HCl |
229.70478 | |
|
GSK126
|
1346574-57-9 |
GSK126
|
GSK126;GSK126;GSK-126;GSK 126;CS-694;GSK126;S)-1-(SEC-BUTYL)-N-((4,6-DIMETHYL-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)-3-METHYL-6-(6-(PIPERAZIN-1-YL)PYRIDIN-3-YL)-1H-INDOLE-4-CARBOXAMIDE;CPDB1065;EZH2 INHIBITOR;GSK-126;GSK 126;GSK2816126A;GSK126 (GSK2816126A)
|
C31H38N6O2 |
526.67242 | -0 |
|
IPI-145
|
1201438-56-3 |
IPI-145
|
8-氯-2-苯基-3-[(1S)-1-(7H-嘌呤-6-基氨基)乙基]异喹啉1-1;IPI145;IPI 145;IPI-145. INK-1197;INK 1197;INK1197;DUVELISIB (IPI-145;INK1197);IPI-145 INK197;DUVELISIB (IPI-145);IPI-145 INK197;DUVELISIB (IPI-145);DUVELISIB (IPI-145,INK1197);IPI 145;IPI145;度维利塞;(S)-3-(1-((9H-嘌呤-6-基)氨基)乙基)-8-氯-2-苯基-1(2H)-异喹啉酮
|
C22H16ClN6O |
415.85504 | 200-256-5 |
|
PIK-75
|
372196-67-3 |
2-甲基-5-硝基-1-苯磺酰[2-[(6-溴咪唑并[1,2-A]吡啶-3-基)亚甲基]-1-甲基肼]
|
CS-669;2-甲基-5-硝基-1-苯磺酰[2-[(6-溴咪唑并[1,2-A]吡啶-3-基)亚甲基]-1-甲基肼];PIK-75游离
|
C16H14N5O4SBr |
452.28246 | |
|
R1487 HCl
|
449808-64-4 |
SY-R1487
|
RI-487;R1487;R1487 (SY-R1487);Pyrido[2,3-d]pyriMidin-7(8H)-one, 6-(2,4-difluorophenoxy)-8-Methyl-2-[(tetrahydro-2H-pyran-4-yl)aMino]-, (Hydrochloride) (1:1);6-(2,4-Difluorophenoxy)-8-methyl-2-[(tetrahydro-2H-pyran-4-yl)amino]pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride;R1487 (Hydrochloride)
|
C19H18F2N4O3.HCL |
424.82896 | |
|
JAK Inhibitor I
|
457081-03-7 |
2-(1,1-二甲基乙基)-9-氟-1,6-二氢-7H-苯并[H]咪唑并[4,5-F]异喹啉-7-酮
|
CMP 6;2-(1,1-Dimethylethyl)-9-fluoro-1,6-dihydro-7H-benz[h]imidazo[4,5-f]isoquinolin-7-one;Merck-5 ,JAK INHIBITOR I;JAK Inhibitor;Pyridone 6;CMP 6
2-(1,1-Dimethylethyl)-9-fluoro-1,6-dihydro-7H-benz[h]imidazo[4,5-f]isoquinolin-7-one;JAK Inhibitor I - CAS 457081-03-7 - Calbiochem;JAK Inhibitor I(Merck 5)
|
C18H16N3OF |
309.33754 | |
|
SCH-1473759
|
1094069-99-4 |
SCH1473759
|
CS-662;SCH1473759;2-[乙基[[5-[[6-甲基-3-(1H-吡唑-4-基)咪唑并[1,2-A]吡嗪-8-基]氨基]-3-异噻唑基]甲基]氨基]-2-甲基-1-丙醇
|
C20H26N8OS |
426.53844 | |
|
Ganetespib (STA-9090)
|
888216-25-9 |
GANETESPIB
|
3-(2,4-二羟基-5-异丙基苯基)-4-(1-甲基吲哚-5-基)-5-羟基-4H-1,2,4-三唑;3-(2,4-噻唑;STA-9090;STA 9090;STA9090;STA-9090;STA9090;GANETESPIB (STA-9090);STA-9090;STA 9090;STA9090;3-(2,4-三氮唑;CS-654
|
C20H20N4O3 |
364.3978 | 812-978-3 |
|
N-(4-Chloro-3-methoxyphenyl)-2-pyridinecarboxamide
|
1161205-04-4 |
VU 0361737
|
VU 0361737>98%;1-(3,4-DICHLOROBENZYL)INDOLINE-2,3-DIONE;ML-128;VU-0361737;VU 0361737;ML128;ML 128;N-(4-CHLORO-3-METHOXYPHENYL)PICOLINAMIDE;N-(4-氯-3-甲氧基苯基)-2-吡啶甲酰胺;VU 0361737;ML-128;VU-0361737;VU 0361737;CS-626
|
C13H11N2O2Cl |
262.69164 | 200-256-5 |
|
Laropiprant
|
571170-77-9 |
LAROPIPRANT
|
拉罗皮兰;(R)-2-(4-(4-氯苄基)-7-氟-5-(甲基磺酰基)-1,2,3,4-四氢环戊烷并[B]吲哚-3-基)乙酸;MK0524;LAROPIPRANT;MK-0524;各拉西酮;拉罗皮兰,MK0524;拉罗匹仑;CS-624
|
C21H19ClFNO4S |
435.901 | 682-424-1 |
|
GW2580
|
870483-87-7 |
GW2580
|
5-[[3-甲氧基-4-[(4-甲氧基苯基)甲氧基]苯基]甲基]-2,4-嘧啶二胺;5-[3-甲氧基-4-(4-甲氧基苄氧基)苄基]嘧啶-2,4-二胺;5-[[3-甲氧基-4-[(4-甲氧苯基)甲氧基]苯基]甲基]-2,4-嘧啶二胺
|
C20H22N4O3 |
366.41368 | |
|
ZM 306416 hydrochloride
|
690206-97-4 |
ZM 306416
|
N-(4-氯-2-氟苯基)-6,7-二甲氧基-4-喹唑啉胺;吉非替尼杂质-10;CS-616;ZM-306416;ZM 306416;CB 676475;ZM-306416;ZM306416;CB-676475;CB676475;N-(4-氯-2-氟苯基)-6,7-二甲氧基喹唑啉-4-胺
|
C16H13N3O2FCl.HCl |
370.20566 | |
|
Pifithrin-alpha
|
63208-82-2 |
Pifithrin-α (PFTα)
|
CS-1772;2-(2-亚氨基-4,5,6,7-四氢苯并噻唑-3-基)-1-P-苯甲基乙酮氢溴酸盐;CS-607;PIFITHRIN HYDROBROMIDE;PIFITHRIN-Α HYDROBROMIDE;PFTΑ HYDROBROMIDE;皮斐松
|
C16H19BrN2OS |
367.3 | |
|
ARN-509
|
956104-40-8 |
ARN-509
|
阿帕他胺;阿帕鲁胺;阿帕鲁他胺;ARN 509;ARN-509;ARN-509;ARN 509;ARN509;阿帕鲁胺;4-[7-[6-氰基-5-(三氟甲基)吡啶-3-基]-8-氧代-6-硫代-5,7-二氮杂螺[3.4]辛-5-基]-2-氟-N-甲基苯甲酰;阿帕他胺;阿帕鲁胺(APALUTAMIDE)是第2代非甾体雄激素受体抑制药,用于治疗非转移性去势抵抗前列腺癌
|
C21H15F4N5O2S |
477.4347128 | 807-449-9 |
|
4-(3-(Pyridin-2-yl)-1H-pyrazol-4-yl)quinoline
|
396129-53-6 |
LY 364947
|
4-(3-吡啶-2-基-1H-吡唑-4-基)喹啉;4-[3-(2-吡啶基)-1H-吡唑-4-基]喹啉;LY364947;HTS466284;LY-364947;4-[3-(2-吡啶基)-1H-吡唑-4-基]喹啉LY-364947;LY 364947;LY-364947;LY-364947,HTS 466284>98%;CS-576;LY 364947;LY364947;HTS466284
|
C17H12N4 |
272.30398 | |
|
RITA (NSC 652287)
|
213261-59-7 |
RITA, >99%
|
NSC-652287;NSC 652287;5,5'-(2,5-呋喃二基)二-2-噻吩甲醇;5,5-呋喃二基)二-2-噻吩甲醇 RITA;5-呋喃二基)二-2-噻吩甲醇
|
C14H12O3S2 |
292.37328 | 200-256-5 |
|
WZ 811
|
55778-02-4 |
WZ 811
|
N-[[4-[(吡啶-2-基氨基)甲基]苯基]甲基]吡啶-2-胺;N,N'-(1,4-PHENYLENEBIS(METHYLENE))DIPYRIDIN-2-AMINE;N,N'-二-2-吡啶基-1,4-苯二甲胺
|
C18H18N4 |
290.36232 | 200-256-5 |
|
AS-604850
|
648449-76-7 |
5-[(2,2-二氟-1,3-苯并二恶茂-5-基)亚甲基]噻唑烷-2,4-二酮
|
5-[(2,2-二氟-1,3-苯并二恶茂-5-基)亚甲基]噻唑烷-2,4-二酮;AS604850;AS 604850;AS-604850;5-(2,2-二氟-苯唑[1,3]二氧-5-基亚甲基)-噻唑烷-2,4-二酮;AS-604850;AS 604850
|
C11H5F2NO4S |
285.225 |
药智官方微信
药智官方微博
